According to Globocan 2020 data, there were 185,621 fatal cancer cases and approximately 467,965 new cancer cases in France. According to the Foundation de France, more than 350,000 people are affected by cancer every year, and it claims close to 150,000 lives. This accounts for about one-third of all fatalities. Deoxyribonucleic acid (DNA) and gene chips (microarrays) are becoming more and more important in emerging economies, and people in rural areas are becoming more and more aware of them. As a result, it is discovered that deoxyribonucleic acid (DNA) and gene chips (microarrays) play a crucial role in risk assessment and early diagnosis.
According to Data Bridge Market Research, Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market was USD 13.24 billion in 2022, would rocket up to USD 36.74 billion by 2030, and is expected to undergo a CAGR of 13.6% during the forecast period 2023 to 2030.
“Advancements in genomics research surge market demand”
Advancements in genomics research have enhanced our understanding of DNA and gene functions in diseases and biological processes. This has fueled the demand for DNA and gene chip technologies, which enable researchers to analyze gene expression, genotyping, and DNA sequencing. The ability to study these aspects at a large scale and high-throughput level has accelerated research and drug development, driving the growth of the DNA and gene chip market in various fields of study and application.
What restraints the growth of the deoxyribonucleic acid (DNA) and gene chip (microarrays) market?
"High cost can impede the market growth”
The high costs associated with microarray technology pose a significant restraint in the DNA and gene chip market. The initial investment required for instruments, consumables, and data analysis software, along with ongoing expenses, can be a financial burden for many users. This limits the affordability and accessibility of microarrays, particularly for smaller research labs or healthcare facilities with limited budgets. Addressing cost concerns and exploring cost-effective alternatives are essential for wider adoption and market growth in this field.
Segmentation: Global Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market
The deoxyribonucleic acid (DNA) and gene chip (microarrays) market is segmented on the basis of product, type, application, and end user.
- On the basis of product, the deoxyribonucleic acid (DNA) and gene chip (microarrays) market is segmented into consumables and instrumentation.
- On the basis of type, the deoxyribonucleic acid (DNA) and gene chip (microarrays) market is segmented into oligonucleotide dna microarrays (DNA), and complementary dna microarrays (CDNA).
- On the basis of application, the deoxyribonucleic acid (dna) and gene chip (microarrays) market is segmented into gene expression, cancer diagnostics, and treatments, drug discovery, genetics, snp analysis, screening and monitoring of patient data during clinical trials, proteomics, toxicogenomics, microbial genotyping, agricultural biology, environmental control.
- On the basis of end user, the deoxyribonucleic acid (DNA) and gene chip (microarrays) market is segmented into academic and research institutes, biotechnological and pharmaceutical companies, and research laboratories.
Regional Insights: North America dominates the Global Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market
North America dominates the deoxyribonucleic acid (DNA) and gene chip (microarrays) market owing to the strong healthcare system, rising financial commitments from leading industry participants to the creation of cutting-edge devices, and an expansion of the processes used in drug development. The expansion of research initiatives in this field, the detection of some tumors, and the monitoring of the biological response to cancer therapy are other factors that contribute to the market growth.
Asia-Pacific is expected to witness significant growth owing to the growth of public awareness initiatives, an increase in medical travel, an increase in regional research activity, an increase in cancer prevalence, and an increase in demand for high-quality healthcare.
To know more about the study, visit, https://www.databridgemarketresearch.com/pt/reports/global-dna-and-gene-chip-microarrays-market
Recent Developments in Global Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market
- In 2020, In order to introduce a CRISPR-Cas9-based biosensor diagnostic device using a graphene transistor known as CRISPR-Chip, two significant companies named Cardea Bio and Nanosens Innovations worked together.
The Prominent Key Players Operating in the Global Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Include:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Thermo Fisher Scientific (U.S.)
- Abbott (U.S.)
- QIAGEN (Germany)
- PerkinElmer, Inc. (U.S.)
- Merck KGaA (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Enzo Biochem, Inc. (U.S)
- Charles River Laboratories (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Bruker (U.S.)
- Siemens (U.S.)
- General Electric (U.S.)
- Oxford Gene Technology IP Limited (U.K.)
- Gyros Protein Technologies AB (U.K.)
- Macrogen, Inc (South Korea)
- BIONEER CORPORATION (South Korea)
Above are the key players covered in the report, to know about more and exhaustive list of deoxyribonucleic acid (DNA) and gene chip (Microarrays) market companies contact, https://www.databridgemarketresearch.com/pt/contact
Research Methodology: Global Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
